BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6
5 results:

  • 1. Evaluation of Combined cancer Markers With Lactate Dehydrogenase and Application of Machine Learning Algorithms for Differentiating Benign Disease From Malignant Ovarian cancer.
    Jeong S; Son DS; Cho M; Lee N; Song W; Shin S; Park SH; Lee DJ; Park MJ
    Cancer Control; 2021; 28():10732748211033401. PubMed ID: 34923833
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection.
    Cirillo PDR; Margiotti K; Fabiani M; Barros-Filho MC; Sparacino D; Cima A; Longo SA; Cupellaro M; Mesoraca A; Giorlandino C
    PLoS One; 2021; 16(8):e0255804. PubMed ID: 34352040
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A practical method to screen and identify functioning biomarkers in nasopharyngeal carcinoma.
    Liu C; Guo P; Zhou L; Wang Y; Tian S; Ding Y; Wu J; Zhu J; Wang Y
    Sci Rep; 2021 Mar; 11(1):7294. PubMed ID: 33790390
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnostic value of human epididymis protein 4 compared with mesothelin for ovarian cancer: a systematic review and meta-analysis.
    Lin JY; Qin JB; Li XY; Dong P; Yin BD
    Asian Pac J Cancer Prev; 2012; 13(11):5427-32. PubMed ID: 23317195
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas.
    O'Neal RL; Nam KT; LaFleur BJ; Barlow B; Nozaki K; Lee HJ; Kim WH; Yang HK; Shi C; Maitra A; Montgomery E; Washington MK; El Rifai W; Drapkin RI; Goldenring JR
    Hum Pathol; 2013 May; 44(5):734-42. PubMed ID: 23084584
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.